Viewing Study NCT03179761


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2025-12-27 @ 9:34 PM
Study NCT ID: NCT03179761
Status: COMPLETED
Last Update Posted: 2024-12-04
First Post: 2017-06-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients
Sponsor: Vanderbilt-Ingram Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: VICC CTT 1733
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators